BD3633045
Benznidazole , 95% , 22994-85-0
| Pack Size | Price | Stock | Quantity |
| 25mg | RMB360.00 | In Stock |
|
| 50mg | RMB539.20 | In Stock |
|
| 100mg | RMB808.00 | In Stock |
|
| others | Enquire |
Update time: 2022-07-08
PRODUCT Properties
| Melting point: | 189-192 °C (lit.) |
| Density | 1.35±0.1 g/cm3(Predicted) |
| storage temp. | Sealed in dry,Room Temperature |
| solubility | methanol: soluble50mg/mL, clear, colorless to yellow |
| pka | 14?+-.0.46(Predicted) |
| form | Solid |
| color | White to Off-White |
| Water Solubility | 0.4g/L(temperature not stated) |
| Merck | 13,1085 |
| BCS Class | 3 |
Description and Uses
Benznidazole is the second of the drugs approved for treatment of Chagas' disease. Like nifurtimox, it is effective against the circulating form of Trypanosoma cruzi during the acute phase of the disease, but also like nifurtimox, it is ineffective during the chronic stage of the disease.
Benznidazole (BNZ) is traditionally used to treat Chagas disease caused by Trypanosoma cruzi. The drugs used for the treatment of this disease, Nifurtimox and Benznidazole, are toxic and present sever e side effects.
Safety
| Symbol(GHS) |  GHS07 |
| Signal word | Warning |
| Hazard statements | H315-H319-H335 |
| Precautionary statements | P261-P264-P271-P280-P302+P352-P305+P351+P338 |
| Hazard Codes | Xi |
| Risk Statements | 36/37/38 |
| Safety Statements | 26-36 |
| WGK Germany | 3 |
| RTECS | NI3340000 |
